We know that head lice is a problem that affects hundreds of millions around the world. We are developing a natural, effective, safe, and convenient solution that would eradicate the problem in a single treatment.
Mor has served as clinical director and product manager at leading Israeli medical and esthetics companies. At Viora, an international medical device company in the aesthetic dermatology field, she planned and executed pre-clinical and international clinical trials, worked with R&D to continue developing the product based on the trials and feedback, and worked closely with the regulatory department to obtain CE and FDA approvals. At Zeiss, she performed clinical training for surgical microscopy in Israeli hospitals, often giving support in operating rooms. She holds an MSc from the Department of Genetics and Molecular Developmental Biology at Ben-Gurion University, and an MBA from Tel Aviv University.
More than 20 years of experience as General Manager and founder of biotech, pharmaceutical, and medical device companies. Served as a fighter pilot and a commander in the Israel Air Force. David initiated and managed Cure Medical; a 10,000 square ft. plant for IV solutions for dialysis, and chemotherapy drugsMr. Tavor has also served as the CEO of Hadas Natural Products, Minapro (micro algae), and Purewaters (water purification). Mr. Tavor managed Fluorinex, a dental care company that developed a fluoridation and teeth whitening device that was sold in the USA, Canada, and Israel. David is the active Chairman of PharMedica Ltd. and Plaqless Ltd. and is also Colgate’s business representative in Israel for identifying technologies for acquisition, investment, and cooperation. Mr. Tavor holds an MA in Political Science and National Defense Studies, and MBA studies.
Over 5 years of experience as R&D and project manager at biomedical startups. He holds a BSc in Biomedical Engineering from Ben-Gurion University.
Over 22 years of experience in managing R&D and engineering of multidisciplinary systems. Prior to joining ParaSonic, he served as VP of New Technologies and VP of R&D at leading medical device companies in fields such as esthetics, cardiac surgery and diagnostic ultrasound. He has experience in initiating the development of new products based on novel technologies, and establishing international collaborations with strategic partners. He holds a BSc in Electrical Engineering from the Technion, MSc in Biomedical Engineering from Tel Aviv University, and an MBA from Bar-Ilan University
Board of Directors
Managing director of Jacobs Investment Company LLC, San Diego, CA. Chairman of DermTech International, Nutrinia Ltd., GEO2 Technologies Inc., and director at Fallbrook Technologies.
CEO and Managing partner of NGT VC 3.
Former CEO and director of Beta-O2 Technologies. Brought the company to be one of the world leaders in the industry.
Served as CEO of the Technion Entrepreneurial Incubator (TEIC). Led the establishment and investment in more than 40 companies.
Gained a wide range of experience in identifying new technologies and in establishing, directing, and creating value for technology-based start-up companies.
Served as a member of the Technion’s Patent Committee. (1998 – 2006).
Zohar holds an M.Sc. in material engineering, a B.Sc. in physics, and a certificate in business management, all from the Technion, Israel Institute of Technology.